Keywords: Genzyme, Sanofi, Isis Pharma, Kynamro, HoFH, Cholesterol disorder

Genzyme and Isis file Kynamro NDA in USA

Article | 02 April 2012

Print This

Biotech firm Genzyme, a subsidiary of French drug major Sanofi (Euronext: SAN), has submitted a New Drug Application to the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in